A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Squamous Cell Carcinoma of Head and Neck · Sinus Cancer · Nasal Cavity Cancer · Oral Cavity Cancer · Oropharynx Cancer · Hypopharynx Cancer · Larynx Cancer · Oral Squamous Cell Carcinoma · Oropharynx Squamous Cell Carcinoma · Hypopharynx Squamous Cell Carcinoma · Larynx Squamous Cell Carcinoma · HPV Positive Oropharyngeal Squamous Cell Carcinoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Winston Wong, MD) · 646-608-4245
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

    Contact: Study coordinator (Winston Wong, MD) · 646-608-4245
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

    Contact: Study coordinator (Winston Wong, MD) · 646-608-4245
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack, New York, United States

    Contact: Study coordinator (Winston Wong, MD) · 646-608-4245
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

    Contact: Study coordinator (Winston Wong, MD) · 646-608-4245
  • Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York, New York, United States

    Contact: Study coordinator (Winston Wong, MD) · 646-608-4245
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States

    Contact: Study coordinator (Winston Wong, MD) · 646-608-4245
מובילי המחקר
  • Winston Wong, MD

    Principal Investigator

    Memorial Sloan Kettering Cancer Center